Purpose

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements. 2. Patient has been or is intended to be treated with an eligible registry device.* 3. Patient is age ≥ 18 years at time of informed consent signature. - The intent to treat a patient with a Gore product must be made prior to soliciting for possible registry participation. If pre-procedure consent is not feasible due to emergent situation, consent prior to the time of discharge for the index procedure is acceptable.

Exclusion Criteria

  1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures. 2. Patient with exclusion criteria required by local law. 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study* within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol. - The term "study" does not apply to other observational registries or quality improvement projects. Collection of Registry Device performance from interventional studies may be permissible provided device application is not investigational and there are no novel requirements that alter follow-up conduct (i.e., protocol-mandated interventions).

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Aneurysm/Other Isolated Lesion
  • Device: Endovascular
    TEVAR - thoracic endovascular aortic repair
Dissection
  • Device: Endovascular
    TEVAR - thoracic endovascular aortic repair

Recruiting Locations

University of Arizona
Tucson, Arizona 85724
Contact:
Karen Site Coordinator
kas10@arizona.edu

University of Southern California
Los Angeles, California 90033
Contact:
Stephanie Site Coordinator
stephanie.varela@med.usc.edu

Cedars-Sinai Medical Center
Los Angeles, California 90048
Contact:
Ayda Site Coordinator
Ayda.Aliyari@cshs.org

Leland Stanford Junior University
Stanford, California 94305
Contact:
Suneetha Site Coordinator
satluri2@stanford.edu

University of Florida - Gainesville
Gainesville, Florida 32610
Contact:
Nancy Site Coordinator
nancy.hanson@surgery.ufl.edu

University of South Florida
Tampa, Florida 33606
Contact:
Avennette Site Coordinator
apinto3@usf.edu

Augusta University
Augusta, Georgia 30912
Contact:
Yvonne Site Coordinator
yvdaniel@augusta.edu

Indiana University School of Medicine
Indianapolis, Indiana 46202
Contact:
Terri Strickland
TStrickland@IUHealth.org

University of Maryland - Baltimore
Baltimore, Maryland 21201
Contact:
Langford Site Coordinator
lwgreen@som.umaryland.edu

The Hitchcock Foundation at Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire 03756
Contact:
Paulene Site Coordinator
pauline.sirrell@hitchcock.org

Hackensack University Medical Center
Hackensack, New Jersey 07601
Contact:
Stephanie Site Coordinator
Stephanie.lynes@hmhn.org

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
Contact:
Amber Site Coordinator
amber_fix@med.unc.edu

Duke University
Durham, North Carolina 27710
Contact:
Hillary Site Coordinator
hillary.hood@duke.edu

University Hospitals - Cleveland Medical Center
Cleveland, Ohio 44106
Contact:
Camille Site Coordinator
Camille.Opperman@uhhospitals.org

Baylor Research Institute
Dallas, Texas 75246
Contact:
Sarah Site Coordinator
SarahAnn.Hooton@BSWHealth.org

Columbia Medical Center of Plano
Plano, Texas 75075
Contact:
Pauline Site Coordinator
pauline.matheri@hcahealthcare.com

Intermountain Medical Center
Murray, Utah 84157
Contact:
Lexi Site Coordinator
lexi.maycock@imail.org

Sentara Medical Group, Sentara Norfolk General Hospital
Norfolk, Virginia 23437
Contact:
Kara Site Coordinator
kvwiggin@sentara.com

University of Wisconsin
Madison, Wisconsin 53792
Contact:
Nicole Site Coordinator
byington@surgery.wisc.edu

More Details

Status
Recruiting
Sponsor
W.L.Gore & Associates

Study Contact

Ashley Hoedt, MS
+1 928-864-3987
ahoedt@wlgore.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.